Enantioseparation of chiral phytocannabinoids in medicinal cannabis.

The evaluation of the chiral composition of phytocannabinoids in the cannabis plant is particularly important as the pharmacological effects of the (+) and (-) enantiomers of these compounds are completely different. Chromatographic attempts to assess the presence of the minor (+) enantiomers of the main phytocannabinoids, cannabidiolic acid (CBDA) and trans-Δ9-tetrahydrocannabinolic acid (trans-Δ9-THCA), were carried out on heated plant extracts for the determination of the corresponding decarboxylated species, cannabidiol (CBD) and trans-Δ9-tetrahydrocannabinol (trans-Δ9-THC), respectively. This process produces an altered phytocannabinoid composition with several new and unknown decomposition products. The present work reports for the first time the stereoselective synthesis of the pure (+) enantiomers of the main phytocannabinoids, trans-CBDA, trans-Δ9-THCA, trans-CBD and trans-Δ9-THC, and the development and optimization of an achiral-chiral liquid chromatography method coupled to UV and high-resolution mass spectrometry detection in reversed phase conditions (RP-HPLC-UV-HRMS) for the isolation of the single compounds and evaluation of their actual enantiomeric composition in plant. The isolation of the peaks with the achiral stationary phase ensured the absence of interferences that could potentially co-elute with the analytes of interest in the chiral analysis. The method applied to the Italian medicinal cannabis variety FM2 revealed no trace of the (+) enantiomers for all phytocannabinoids under investigation before and after decarboxylation, thus suggesting that the extraction procedure does not lead to an inversion of configuration.

[1]  R. Aparasu,et al.  Clinical efficacy and safety of cannabidiol for pediatric refractory epilepsy indications: A systematic review and meta-analysis , 2022, Experimental Neurology.

[2]  A. Cavazzini,et al.  Investigation of retention behavior of natural cannabinoids on differently substituted polysaccharide-based chiral stationary phases under reversed-phase liquid chromatographic conditions. , 2022, Journal of chromatography. A.

[3]  C. Laezza,et al.  Cannabinoids: Therapeutic Use in Clinical Practice , 2022, International journal of molecular sciences.

[4]  A. Cavazzini,et al.  Investigating the effect of polarity of stationary and mobile phases on retention of cannabinoids in normal phase liquid chromatography , 2022, Analytical and Bioanalytical Chemistry.

[5]  G. Gigli,et al.  The novel heptyl phorolic acid cannabinoids content in different Cannabis sativa L. accessions. , 2021, Talanta.

[6]  Weston J Umstead,et al.  The Separation of Cannabinoids on Sub-2 µm Immobilized Polysaccharide Chiral Stationary Phases , 2021, Pharmaceuticals.

[7]  A. Capriotti,et al.  Recent applications of mass spectrometry for the characterization of cannabis and hemp phytocannabinoids: From targeted to untargeted analysis. , 2021, Journal of chromatography. A.

[8]  F. Marini,et al.  Phytocannabinomics: Untargeted metabolomics as a tool for cannabis chemovar differentiation. , 2021, Talanta.

[9]  E. Carreira,et al.  Δ9-cis-Tetrahydrocannabinol: Natural Occurrence, Chirality, and Pharmacology. , 2021, Journal of natural products.

[10]  A. K. Mishra,et al.  Pharmacological properties, therapeutic potential, and legal status of Cannabis sativa L.: An overview , 2021, Phytotherapy research : PTR.

[11]  G. Gigli,et al.  HPLC-UV-HRMS analysis of cannabigerovarin and cannabigerobutol, the two impurities of cannabigerol extracted from hemp. , 2021, Journal of pharmaceutical and biomedical analysis.

[12]  B. Fiebich,et al.  (+)-trans-Cannabidiol-2-hydroxy pentyl is a dual CB1R antagonist/CB2R agonist that prevents diabetic nephropathy in mice. , 2021, Pharmacological research.

[13]  John F. Trant,et al.  The biosynthesis of the cannabinoids , 2021, Journal of Cannabis Research.

[14]  J. Crippa,et al.  Neuropharmacological Effects of the Main Phytocannabinoids: A Narrative Review. , 2020, Advances in experimental medicine and biology.

[15]  G. Gigli,et al.  Identification of a new cannabidiol n-hexyl homolog in a medicinal cannabis variety with an antinociceptive activity in mice: cannabidihexol , 2020, Scientific Reports.

[16]  A. Capriotti,et al.  Improved identification of phytocannabinoids using a dedicated structure-based workflow. , 2020, Talanta.

[17]  Pellegrino Cerino,et al.  A Review of Hemp as Food and Nutritional Supplement. , 2020, Cannabis and cannabinoid research.

[18]  G. Gigli,et al.  Isolation of a High-Affinity Cannabinoid for the Human CB1 Receptor from a Medicinal Cannabis sativa Variety: Δ9-Tetrahydrocannabutol, the Butyl Homologue of Δ9-Tetrahydrocannabinol. , 2019, Journal of natural products.

[19]  G. Gigli,et al.  A novel phytocannabinoid isolated from Cannabis sativa L. with an in vivo cannabimimetic activity higher than Δ9-tetrahydrocannabinol: Δ9-Tetrahydrocannabiphorol , 2019, Scientific Reports.

[20]  G. Gigli,et al.  Analysis of impurities of cannabidiol from hemp. Isolation, characterization and synthesis of cannabidibutol, the novel cannabidiol butyl analog. , 2019, Journal of pharmaceutical and biomedical analysis.

[21]  G. Gigli,et al.  Chemical and spectroscopic characterization data of ‘cannabidibutol’, a novel cannabidiol butyl analog , 2019, Data in brief.

[22]  Giuseppe Cannazza,et al.  Pharmaceutical and biomedical analysis of cannabinoids: A critical review , 2018, Journal of pharmaceutical and biomedical analysis.

[23]  F. Gasparrini,et al.  Cannabis through the looking glass: chemo- and enantio-selective separation of phytocannabinoids by enantioselective ultra high performance supercritical fluid chromatography. , 2017, Chemical communications.

[24]  D. Centonze,et al.  Cannabinoids therapeutic use: what is our current understanding following the introduction of THC, THC:CBD oromucosal spray and others? , 2017, Expert review of clinical pharmacology.

[25]  G. Rastelli,et al.  An unexpected reversal in the pharmacological stereoselectivity of benzothiadiazine AMPA positive allosteric modulators , 2016 .

[26]  G. Appendino,et al.  Phytocannabinoids: a unified critical inventory. , 2016, Natural product reports.

[27]  V. Schurig.  The Reciprocal Principle of Selectand-Selector-Systems in Supramolecular Chromatography † , 2016, Molecules.

[28]  M. Zoli,et al.  "Heart-cut" bidimensional achiral-chiral liquid chromatography applied to the evaluation of stereoselective metabolism, in vivo biological activity and brain response to chiral drug candidates targeting the central nervous system. , 2016, Journal of chromatography. A.

[29]  E. Carreira,et al.  Stereodivergent total synthesis of Δ9-tetrahydrocannabinols. , 2014, Angewandte Chemie.

[30]  Y. Choi,et al.  NMR assignments of the major cannabinoids and cannabiflavonoids isolated from flowers of Cannabis sativa. , 2004, Phytochemical analysis : PCA.

[31]  M. Herkenham,et al.  International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors , 2002, Pharmacological Reviews.

[32]  S. Levin,et al.  Role of hydroxyl groups in chiral recognition of cannabinoids by carbamated amylose , 1994 .

[33]  R. Mechoulam,et al.  Resolution of chiral cannabinoids on amylose tris(3,5-dimethylphenylcarbamate) chiral stationary phase: effects of structural features and mobile phase additives. , 1993, Journal of chromatography. A.

[34]  Y. Shoyama,et al.  Tetrahydrocannabinolic acid, a genuine substance of tetrahydrocannabinol. , 1967, Chemical & pharmaceutical bulletin.

[35]  Philip R. Cohen.  Therapeutic and Cosmetic Uses of Cannabis: Cannabinoids for Acne Treatment and Skin -Rejuvenation. , 2021, Skinmed.

[36]  S. Levin,et al.  Structural features affecting chiral resolution of cannabimimetic enantiomers by amylose 3,5‐dimethylphenylcarbamate chiral stationary phase , 1995 .

[37]  R. Mechoulam,et al.  Carboxylation of resorcinols with methylmagnesium carbonate. Synthesis of cannabinoid acids , 1969 .

[38]  O. Schultz,et al.  Zur Frage der Biosynthese der Cannabinole , 1960 .